Wakely Wire
October 30, 2025
New Insights
Whitepapers, briefs, press releases and more
Week in Washington 10/30/25
Shutdown Still no updates on an end to the government shutdown. Senate Majority leader John Thune announced that discussions would be held soon on potentially ending the shutdown. Shutdown effects are expected to grow in the coming weeks. CBO estimated that the shutdown would lower annualized GDP growth in the fourth quarter by 1.0 to ... Continue reading
Events & More
2026 Star Ratings: Trends, Takeaways, and What’s Next
November 6, 2025
1:00 PM ET
Join Wakely, an HMA Company, for a deep dive into the 2026 Medicare Advantage Star Ratings. We’ll unpack what this year’s results mean for plans, including the projected impact on 2027 Medicare Advantage payments.
Our experts will walk through key program and performance trends, highlight the effects of another annual cut point increase, and share insights on what plans can expect over the next few years. We’ll also explore upcoming Star Ratings changes and their potential implications for Medicare Advantage Organizations (MAOs).
Whether you’re looking to understand the numbers or plan your next steps, this session will help you stay ahead of the curve.
Value Based Care Advisory Services: HMA and Wakely Put Analysis into Action
November 20, 2025
1:00 PM ET
Join experts from HMA and Wakely, an HMA Company, for an inside look at how our teams help organizations navigate and thrive in the value-based landscape. This session will highlight case studies and recent work that demonstrate a comprehensive advisory solution for any value-based entity. Attendees will gain a deeper understanding of how integrated insights across strategy, analytics, and implementation can drive measurable results in value-based care.
Newsworthy Findings
Centene Posts $6.6B Loss on Massive Value Writedown
The goodwill impairment charge is meant to realign Centene’s value on its own books with the company’s value in the markets, which has plummeted this year amid medical cost and policy headwinds.
Senators Show Bipartisan Support for Reforming 340B During HELP Hearing
Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating facilities.
EmblemHealth Taps Prime Therapeutics, Amazon for New Pharmacy Benefit Collaboration
EmblemHealth is partnering with Prime Therapeutics and Amazon to overhaul its pharmacy-benefit model by leveraging real-time referrals for specialty drugs, digital savings tools, and home delivery options to offer more transparent, convenient, and cost-effective access for members.
As AI Pushes Further Ahead of Governance Strategies, Only Some Vendors Are Stepping Up
While the use of artificial intelligence in healthcare vendors is rapidly maturing, the industry has yet to develop and implement consistent governance and evaluation frameworks for overseeing these tools post-deployment.
Q3 Earnings Recap: For-Profit Hospitals' Revenues Spike on Medicaid Supplemental Payments
Favorable shifts in patients’ source of insurance coverage played a key role in earnings increase, as did the acuity of cases and services being provided, the rates hospitals were able to demand and revenue cycle teams tasked with promptly winning claims disputes with payers.
Bonus Article
Mayo Clinic Researchers Find Enhancing the Body’s ‘First Responder’ Cells May Boost Immune Therapy for Cancer
Just for Fun
Math Joke:
Why did the polynomial get therapy?
Prior Week
Q: What did zero say to eight?
A: Nice Belt!
Sign up for the
Wakely Wire,
our industry newsletter.
